CoChat

Disease activity, severity, and damage in the UK juvenile‐onset systemic lupus erythematosus cohort

Open access
Watson, Louise, Leone, Valentina, Pilkington, Clarissa, Tullus, Kjell, Rangaraj, Satyapal, McDonagh, Janet E., Gardner‐Medwin, Janet, Wilkinson, Nick, Riley, Phil, Tizard, Jane, Armon, Kate, Sinha, Manish D., Ioannou, Yiannis, Archer, Neil, Bailey, Kathryn, Davidson, Joyce, Baildam, Eileen M., Cleary, Gavin, McCann, Liza J., Beresford, Michael W., on behalf of the UK Juvenile‐Onset Systemic Lupus Erythematosus Study Group · 2012 · Arthritis & Rheumatism
Cited by 228

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Objective: The UK Juvenile‐Onset Systemic Lupus Erythematosus (JSLE) Cohort Study is a multicenter collaborative network established with the aim of improving the understanding of juvenile SLE. The present study was undertaken to describe the clinical manifestations and disease course in patients with juvenile SLE from this large, national inception cohort. Methods: Detailed data on clinical phenotype were collected at baseline and at regular clinic reviews and annual followup assessments in 232 patients from 14 centers across the UK over 4.5 years. Patients with SLE were identified according to the American College of Rheumatology (ACR) SLE classification criteria. The present cohort comprised children with juvenile SLE (n = 198) whose diagnosis fulfilled ≥4 of the ACR criteria for SLE. Results: Among patients with juvenile SLE, the female:male sex distribution was 5.6:1 and the median age at diagnosis was 12.6 years (interquartile range 10.4–14.5 years). Male patients were younger than female patients (P < 0.01). Standardized ethnicity data demonstrated a greater risk of juvenile SLE in non‐Caucasian UK patients (P < 0.05). Scores on the pediatric adaptation of the 2004 British Isles Lupus Assessment Group disease activity index demonstrated significantly increased frequencies of musculoskeletal (82%), renal (80%), hematologic (91%), immunologic (54%), and neurologic (26%) involvement among the patients over time. A large proportion of the patients (93%) were taking steroids and 24% of the patients required treatment with cyclophosphamide. Disease damage was common, with 28% of the patients having a Systemic Lupus International Collaborating Clinics/ACR damage score of ≥1. Conclusion: The data on these patients from the UK JSLE Cohort Study, comprising one of the largest national inception cohorts of patients with juvenile SLE to date, indicate that severe organ involvement and significant disease activity are primary characteristics in children with juvenile SLE. In addition, accumulation of disease‐associated damage could be seen.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.34410

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 228

Metadata

Authors
Watson, L., Leone, V., Pilkington, C., Tullus, K., Rangaraj, S., McDonagh, J. E., Gardner‐Medwin, J., Wilkinson, N., Riley, P., Tizard, J., Armon, K., Sinha, M. D., Ioannou, Y., Archer, N., Bailey, K., Davidson, J., Baildam, E. M., Cleary, G., McCann, L. J., Beresford, M. W., & on behalf of the UK Juvenile‐Onset Systemic Lupus Erythematosus Study Group
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2012-06-26
Volume
64
Issue
7
Pages
2356-2365
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2010623154
Cited by
228
References
3
FWCI
11.54
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.